Congenital Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2026-06-12
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2026
PRAC evaluated new data on potential risk of neurodevelopmental disorders in children born to men treated with valproate.